S. 3420 · 115th Congress
Accountability in Opioid Advertising Act
- Stage
- In committee
- Sponsor
- Kamala Harris
- Introduced
- 2018-09-06
- Latest action
- 2018-09-06 · Introduced in Senate
Summary
Accountability in Opioid Advertising Act
This bill requires the Food and Drug Administration to prioritize the review of advertising and other promotional materials for drug for serious, life-threatening diseases or conditions or substance use disorders, especially opioids (drugs with effects similar to opium, such as certain pain medications)and drugs used in the treatment of opioid use disorders.